<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">751</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>ESTIMATION OF SERUM LIPOPROTEIN (A), LIPID PROFILE AND HBA1C IN PATIENTS WITH TYPE 2 DIABETES MELLITUS - A CASE CONTROL STUDY&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pujar</surname><given-names>Sunita</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hiremath</surname><given-names>Kavitha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pujar</surname><given-names>L.L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Prasad</surname><given-names>Shankar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bhuthal</surname><given-names>Mahanthesh</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>10</day><month>10</month><year>2014</year></pub-date><volume>)</volume><issue/><fpage>54</fpage><lpage>58</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Objective: Diabetes is a major worldwide health problem, leading to markedly increased mortality and serious morbidity. It is characterised by chronic hyperglycemia resulting from a diversity of aetiologies and environmental and genetic factors acting together. Type 2 diabetes mellitus itself leads to dyslipidemia like elevated triglyceride levels and low HDL levels, which are known risk factors for coronary artery disease (CAD). Increased lipoprotein (a)[Lp(a)] concentrations are predictive of CAD. The__ampersandsignnbsp;study was designed to estimate serum lipoprotein (a) and glycosylated hemoglobin (HbA1c) in south Indian patients with type 2 diabetes mellitus and compare them with healthy controls. Material and Methods: The study included 50 patients of type 2 diabete mellitus and 50 age and sex matched controls. Fasting venous blood sample was analysed for fasting blood glucose(FBS), glycated hemoglobin (HbA1c), lipid profile and serum Lp(a). Statistical analysis was done using student t test. Results: The serum Lp(a) and HbA1c levels were significantly elevated in type 2 diabetics compared to healthy controls (p__ampersandsignlt;0.001). There was significant elevation in the levels of FBG ,total cholesterol, total triglyceride, LDL cholesterol and TC/HDLcholesterol ratio in type2 diabetics compared to the control group(p__ampersandsignlt;0.05). Conclusion: Diabetic patients have higher levels of serum Lp(a) and HbA1c compared to healthy controls. Serum Lp(a) associated with lipid abnormalities - high total cholesterol, high triglyceride ,high LDL and low HDL makes diabetics prone for CAD.__ampersandsignnbsp;&#13;
</p></abstract><kwd-group><kwd>Type 2 diabetes mellitus</kwd><kwd> Glycated hemoglobin</kwd><kwd> Lipid profile</kwd><kwd> Lipoprotein a</kwd></kwd-group></article-meta></front></article>
